Norethindrone Acetate Tablet
Product Images NDC 65162-475

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate (NDC 65162-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

898a98a2-figure-01 (Norethindrone Acetate Tablets Usp 1)

Chemical structure diagram of norethindrone, the active ingredient in Norethindrone Acetate 5 mg tablets by Amneal Pharmaceuticals LLC. The image shows the steroid backbone with specific functional groups and bonds characteristic of norethindrone's molecular structure.*

FDA Label Image

898a98a2-figure-02 (Norethindrone Acetate Tablets Usp 2)

A line graph showing the concentration in nanograms per milliliter (ng/ml) of Norethindrone Acetate over time in hours (h). The graph depicts a rapid increase to a peak concentration followed by a gradual decline over a 36-hour period.*

FDA Label Image

90 Ct. (Norethindrone Acetate Tablets Usp 3)

Norethindrone Acetate Tablets, USP 5 mg oral tablets label from Amneal Pharmaceuticals LLC, for a 90 tablet container. The label states the tablets contain 5 mg norethindrone acetate as an orally active progestin. It includes storage instructions, dispensing and medication safety information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.